Last updated: November 14, 2023
Sponsor: Methodist Health System
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Pericardial Closure Using Gentrix Following Cardiac Surgery
Clinical Study ID
NCT06136182
016.SUR.2023.M
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Must have undergone a Coronary Artery Bypass Grafting(CABG) or valverepair/replacement surgery requiring pericardial reconstruction. CABG or valve repair/replacement surgery must have been either elective or urgent status
Exclusion
Exclusion Criteria:
-CABG or valve repair/replacement surgery classified as emergent status Surgery classifiedas redo-sternotomy
Study Design
Total Participants: 489
Treatment Group(s): 1
Primary Treatment: Pericardial Closure Using Gentrix Following Cardiac Surgery
Phase:
Study Start date:
May 12, 2023
Estimated Completion Date:
May 12, 2024
Study Description
Connect with a study center
Clinical Research Institute at Methodist Health System
Dallas, Texas 75203
United StatesActive - Recruiting
Methodist Dallas Medical Center
Dallas, Texas 75203
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.